We report the case of a 65-year-old woman with hyperammonaemic encephalopathy induced by sodium valproate. This is a rare complication of treatment with sodium valproate. The encephalopathy can be reversible on withdrawal of treatment and does carry a risk of morbidity and mortality. This case demonstrates the importance of recognising this potential complication of a drug in common use.
HawkesNDThomasGAOJurewiczA. Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy. Postgrad Med J2001; 77: 717–722.
3.
StewartJ. A case of hyperammonemic encephalopathy after 11 years of valproate therapy. J Clin Psychopharmacol2008; 28(3): 361–362.
4.
BeyenburgSBackCDiederichN. Is valproate encephalopathy under-recognised in older people? A case series. Age Ageing2007; 36(3): 344–346.
5.
GomceliYBKutluGSanivarF. Different clinical manifestations of hyperammonemic encephalopathy. Epilepsy Behav2007; 10(4): 583–587.
